NSPR InspireMD

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

MIAMI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10th at 10:00am Eastern Time (ET).

A live audio webcast and replay of the presentation may be accessed on the “Investor Calendar” section of the company’s website at:

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit

Investor Contacts:

Webb Campbell

Gilmartin Group LLC





EN
27/08/2025

Underlying

NSPRInspireMD

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on InspireMD

 PRESS RELEASE
Free
NSPR INSPIREMD

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global In...

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference MIAMI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10th at 10:00am Eastern Time (ET). A live audio webcast and replay of the presentation may be accessed on the “Investor Calendar” section of the company’s website at: About InspireMD, Inc.InspireMD seeks to utilize it...

20h / 38m 1 EN
 PRESS RELEASE
Free
NSPR INSPIREMD

InspireMD Reports Second Quarter 2025 Financial Results

InspireMD Reports Second Quarter 2025 Financial Results --- Management to host investor conference call today, August 5th, at 8:30am ET --- MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the second quarter and six months ended June 30, 2025. Recent Business Highlights: Received premarket application (PMA) approval from the U.S. Food and Drug Administration (FDA) for the CGuard Prime carotid stent systemCommenced commercial lau...

August 5, 2025 1 EN
 PRESS RELEASE
Free
NSPR INSPIREMD

InspireMD Announces the Appointment of Raymond W. Cohen to its Board o...

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Raymond W. Cohen to its Board of Directors. Mr. Cohen has over 40 years of leadership experience in medical technology with a successful track record of scaling commercial operations and creating shareholder value through market leadership and successful exit transactions. “We are thril...

July 31, 2025 1 EN
 PRESS RELEASE
Free
NSPR INSPIREMD

InspireMD Announces Combined Financings of $58 Million

InspireMD Announces Combined Financings of $58 Million Proceeds Bolster Balance Sheet to Commercialize Recently FDA Approved Best-In-Class Carotid Stent MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the Company has raised approximately $58 million in combined gross proceeds through an equity private placement (“PIPE”) financing and the exercise of warrants that were triggered by the Company’s premarket application approval (“PMA”) of...

July 31, 2025 1 EN
 PRESS RELEASE
Free
NSPR INSPIREMD

InspireMD to Announce Second Quarter 2025 Financial Results

InspireMD to Announce Second Quarter 2025 Financial Results MIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for ...

July 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch